The DLEU2/miR-15a/miR-16-1 cluster shapes the immune microenvironment of chronic lymphocytic leukemia - Summary - MDSpire

The DLEU2/miR-15a/miR-16-1 cluster shapes the immune microenvironment of chronic lymphocytic leukemia

  • By

  • Ronghua Zhang

  • Priyanka Khare

  • Priyanka Banerjee

  • Cristina Ivan

  • Sarah Schneider

  • Federica Barbaglio

  • Karen Clise-Dwyer

  • Vanessa Behrana Jensen

  • Erika Thompson

  • Marisela Mendoza

  • Nicholas Chiorazzi

  • Shih-Shih Chen

  • Xiao-Jie Joy Yan

  • Nitin Jain

  • Paolo Ghia

  • Federico Caligaris-Cappio

  • Rima Mendonsa

  • Sashi Kasimsetty

  • Ryan Swoboda

  • Recep Bayraktar

  • William Wierda

  • Varsha Gandhi

  • George A. Calin

  • Michael J. Keating

  • Maria Teresa Sabrina Bertilaccio

  • October 23, 2024

  • 0 min

Share

Objective:

To investigate the molecular profile and immunophenotype of immune cells exposed to CLL cells and the genetic drivers of protumor immune dysregulation, focusing on the DLEU2/miR-15a/miR-16-1 cluster and its clinical implications.

Key Findings:
  • The DLEU2/miR-15a/miR-16-1 cluster is involved in the protumor function of non-malignant immune cells in CLL, suggesting new avenues for therapeutic intervention.
  • miR-15a/miR-16-1 targets the BCL2 oncogene, influencing both tumor suppression and immune cell behavior, which may inform treatment strategies.
  • BCL2 overexpression in immune cells contributes to immune dysregulation and supports CLL cell survival, highlighting a critical target for therapy.
Interpretation:

The study highlights the dual role of the DLEU2/miR-15a/miR-16-1 cluster in both tumor suppression and the modulation of the immune microenvironment in CLL, suggesting potential therapeutic targets that could enhance treatment efficacy.

Limitations:
  • The molecular mechanisms of protumor functions in immune cells remain poorly understood, which may limit the applicability of findings.
  • The impact of targeted therapies on the immune system in CLL patients needs further investigation to fully understand treatment implications.
Conclusion:

The findings underscore the importance of the DLEU2/miR-15a/miR-16-1 cluster in shaping the immune landscape of CLL, indicating that targeting this pathway may enhance therapeutic strategies and improve patient outcomes.

Original Source(s)

The DLEU2/miR-15a/miR-16-1 cluster shapes the immune microenvironment of chronic lymphocytic leukemia

  • by Ronghua Zhang, Priyanka Khare, Priyanka Banerjee, Cristina Ivan, Sarah Schneider, Federica Barbaglio, Karen Clise-Dwyer, Vanessa Behrana Jensen, Erika Thompson, Marisela Mendoza, Nicholas Chiorazzi, Shih-Shih Chen, Xiao-Jie Joy Yan, Nitin Jain, Paolo Ghia, Federico Caligaris-Cappio, Rima Mendonsa, Sashi Kasimsetty, Ryan Swoboda, Recep Bayraktar, William Wierda, Varsha Gandhi, George A. Calin, Michael J. Keating, Maria Teresa Sabrina Bertilaccio

  • October 23, 2024

Related Content

HIV-related Differences in Placental Immunology: Data From the PRACHITi Cohort in Pune, India

From fetus to 8: the CHILD Cohort Study

Seasonal Incidence of Medically Attended Respiratory Syncytial Virus Infection From 2015 to 2019 in a Cohort of Adults With High-risk Conditions